MRSA treatment 'may be more effective' if alternative drug used
The drug linezolid (Zyvox) may be more effective at treating patients with MRSA nosocomial pneumonia than the current gold standard vancomycin, according to trial results published in the journal Clinical Infectious Diseases.
Continue reading - simply register below
It only takes two minutes to do and you'll immediately have access to our news and opinion articles and you'll be able to sign up for our newsletters.
Already registered?
To check that you are registered please enter your email address below
Not registered?
Registration is free and takes just two minutes. After you register, you'll get access to our news and opinion stories and you'll be able to sign up to our newsletters.
Not activated?
If you are a registered subscriber you also need to activate your subscription in order to access your subscriber-only content and free learning units online.


It’s time to start looking after nurses to boost care





